EL, A., A, B., SR, C., JS, L., & SC, D. (2023). Psoriasiform and lichenoid eruptions as a potential harbinger of bullous dermatoses in the setting of immune checkpoint inhibitors: A case series. International journal of dermatology, 62(7), e411. https://doi.org/10.1111/ijd.16464
Chicago Style (17th ed.) CitationEL, Ahearn, Belzer A, Cohen SR, Leventhal JS, and Deverapalli SC. "Psoriasiform and Lichenoid Eruptions as a Potential Harbinger of Bullous Dermatoses in the Setting of Immune Checkpoint Inhibitors: A Case Series." International Journal of Dermatology 62, no. 7 (2023): e411. https://doi.org/10.1111/ijd.16464.
MLA (9th ed.) CitationEL, Ahearn, et al. "Psoriasiform and Lichenoid Eruptions as a Potential Harbinger of Bullous Dermatoses in the Setting of Immune Checkpoint Inhibitors: A Case Series." International Journal of Dermatology, vol. 62, no. 7, 2023, p. e411, https://doi.org/10.1111/ijd.16464.
